Specific neurotoxicity of chronic use of ecstasy.

Standard

Specific neurotoxicity of chronic use of ecstasy. / Obrocki, J; Schmoldt, A; Buchert, Ralph; Andresen, B; Petersen, K; Thomasius, R.

In: TOXICOL LETT, Vol. 127, No. 1-3, 1-3, 2002, p. 285-297.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Obrocki, J, Schmoldt, A, Buchert, R, Andresen, B, Petersen, K & Thomasius, R 2002, 'Specific neurotoxicity of chronic use of ecstasy.', TOXICOL LETT, vol. 127, no. 1-3, 1-3, pp. 285-297. <http://www.ncbi.nlm.nih.gov/pubmed/12052669?dopt=Citation>

APA

Obrocki, J., Schmoldt, A., Buchert, R., Andresen, B., Petersen, K., & Thomasius, R. (2002). Specific neurotoxicity of chronic use of ecstasy. TOXICOL LETT, 127(1-3), 285-297. [1-3]. http://www.ncbi.nlm.nih.gov/pubmed/12052669?dopt=Citation

Vancouver

Obrocki J, Schmoldt A, Buchert R, Andresen B, Petersen K, Thomasius R. Specific neurotoxicity of chronic use of ecstasy. TOXICOL LETT. 2002;127(1-3):285-297. 1-3.

Bibtex

@article{7640726ef6ff4080acc8eeaf318f2ed5,
title = "Specific neurotoxicity of chronic use of ecstasy.",
abstract = "The use of the illicit drug ecstasy (mainly containing methylenedioxymethamphetamine, MDMA) is widespread among young people in western Nations. Animal experiments indicate that MDMA is a potent neurotoxin specifically affecting the serotonergic system. A few functional neuroimaging studies revealed central nervous alterations after the repeated use of ecstasy. We examined 94 ecstasy users in comparison to 27 control subjects by means of positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG). The FDG uptake rates were globally reduced in ecstasy users, most pronounced in the striatum. The uptake rates tended to be negatively correlated with the cumulative ecstasy doses. The results indicate that younger ecstasy users may be more vulnerable with regard to neurotoxicity.",
author = "J Obrocki and A Schmoldt and Ralph Buchert and B Andresen and K Petersen and R Thomasius",
year = "2002",
language = "Deutsch",
volume = "127",
pages = "285--297",
journal = "TOXICOL LETT",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "1-3",

}

RIS

TY - JOUR

T1 - Specific neurotoxicity of chronic use of ecstasy.

AU - Obrocki, J

AU - Schmoldt, A

AU - Buchert, Ralph

AU - Andresen, B

AU - Petersen, K

AU - Thomasius, R

PY - 2002

Y1 - 2002

N2 - The use of the illicit drug ecstasy (mainly containing methylenedioxymethamphetamine, MDMA) is widespread among young people in western Nations. Animal experiments indicate that MDMA is a potent neurotoxin specifically affecting the serotonergic system. A few functional neuroimaging studies revealed central nervous alterations after the repeated use of ecstasy. We examined 94 ecstasy users in comparison to 27 control subjects by means of positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG). The FDG uptake rates were globally reduced in ecstasy users, most pronounced in the striatum. The uptake rates tended to be negatively correlated with the cumulative ecstasy doses. The results indicate that younger ecstasy users may be more vulnerable with regard to neurotoxicity.

AB - The use of the illicit drug ecstasy (mainly containing methylenedioxymethamphetamine, MDMA) is widespread among young people in western Nations. Animal experiments indicate that MDMA is a potent neurotoxin specifically affecting the serotonergic system. A few functional neuroimaging studies revealed central nervous alterations after the repeated use of ecstasy. We examined 94 ecstasy users in comparison to 27 control subjects by means of positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG). The FDG uptake rates were globally reduced in ecstasy users, most pronounced in the striatum. The uptake rates tended to be negatively correlated with the cumulative ecstasy doses. The results indicate that younger ecstasy users may be more vulnerable with regard to neurotoxicity.

M3 - SCORING: Zeitschriftenaufsatz

VL - 127

SP - 285

EP - 297

JO - TOXICOL LETT

JF - TOXICOL LETT

SN - 0378-4274

IS - 1-3

M1 - 1-3

ER -